And yet no effects of rheumatoid arthritis therapy, remains in the aftermath of the inflammation and treatment, integrated treatment to relieve symptoms and the patients have a certain effect.
2
含塞来昔布药物目前在欧盟被批准用于骨性关节炎、类风湿性关节炎和强直性脊柱炎症状的治疗。
Celecoxib-containing products are currently authorised in the European Union for the treatment of the symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.
点击反馈